Abstract 3227: Components of interleukin-4 signaling are enriched in melanoma patients who respond to anti-PD-1 or anti-CTLA-4 therapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Semmelweis University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409628167
